Corrigendum to “Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial” [Eur. Neuropsychoparmacol. 13 (2003) 267–271]

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103835.559964 ◽

2008 ◽

Author(s):

Deborah Kim

Keyword(s):

Fatty Acids ◽

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽

Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial

BMC Geriatrics ◽

10.1186/s12877-019-1084-4 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 3

Author(s):

Alexandra Schättin ◽

Corinne Baier ◽

Domenique Mai ◽

Verena Klamroth-Marganska ◽

Isabelle Herter-Aeberli ◽

...

Keyword(s):

Fatty Acids ◽

Controlled Trial ◽

The Elderly ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

A randomised, double-blind, placebo-controlled trial of minocycline and/or omega-3 fatty acids added to treatment as usual for at-risk mental states (NAYAB): study protocol

Trials ◽

10.1186/s13063-017-2275-y ◽

2017 ◽

Vol 18 (1) ◽

Cited By ~ 7

Author(s):

Inti Qurashi ◽

Imran B. Chaudhry ◽

Ameer B. Khoso ◽

Sana Farooque ◽

Steve Lane ◽

...

Keyword(s):

Fatty Acids ◽

Study Protocol ◽

Controlled Trial ◽

Mental States ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

Treatment As Usual ◽

Double Blind Placebo ◽

At Risk Mental States

A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder

The Journal of Allergy and Clinical Immunology In Practice ◽

10.1016/j.jaip.2018.01.010 ◽

2018 ◽

Vol 6 (5) ◽

pp. 1604-1612 ◽

Cited By ~ 12

Author(s):

E. Sherwood Brown ◽

Nasreen Sayed ◽

Erin Van Enkevort ◽

Alexandra Kulikova ◽

Alyson Nakamura ◽

...

Keyword(s):

Depressive Disorder ◽

Controlled Trial ◽

Major Depressive ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.12m08093 ◽

2013 ◽

Vol 74 (07) ◽

pp. e636-e641 ◽

Cited By ~ 42

Author(s):

Cristina Cusin ◽

Nadia Iovieno ◽

Dan V. Iosifescu ◽

Andrew A. Nierenberg ◽

Maurizio Fava ◽

...

Keyword(s):

Depressive Disorder ◽

Controlled Trial ◽

Treatment Resistant ◽

Major Depressive ◽

Double Blind ◽

A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2019.0176 ◽

2020 ◽

Vol 30 (6) ◽

pp. 355-365

Author(s):

Robert L. Findling ◽

Emily McCusker ◽

Jeffrey R. Strawn

Keyword(s):

Depressive Disorder ◽

Children And Adolescents ◽

Controlled Trial ◽

Open Label ◽

Major Depressive ◽

Double Blind ◽

International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder

Psychotherapy and Psychosomatics ◽

10.1159/000502652 ◽

2019 ◽

Vol 88 (5) ◽

pp. 263-273 ◽

Cited By ~ 20

Author(s):

Ta-Wei Guu ◽

David Mischoulon ◽

Jerome Sarris ◽

Joseph Hibbeln ◽

Robert K. McNamara ◽

...

Keyword(s):

Fatty Acids ◽

Depressive Disorder ◽

International Society ◽

Practice Guidelines ◽

Research Practice ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

Yearbook of Psychiatry and Applied Mental Health ◽

10.1016/s0084-3970(08)70565-6 ◽

2007 ◽

Vol 2007 ◽

pp. 266

Author(s):

J.C. Ballenger

Keyword(s):

Depressive Disorder ◽

Controlled Trial ◽

Major Depressive ◽

Double Blind ◽

Omega-3 Fatty Acids, Homocysteine, and the Increased Risk of Cardiovascular Mortality in Major Depressive Disorder

Harvard Review of Psychiatry ◽

10.1093/hrp/9.6.280 ◽

2001 ◽

Vol 9 (6) ◽

pp. 280-293 ◽

Cited By ~ 3

Author(s):

W. E. Severus

Keyword(s):

Fatty Acids ◽

Depressive Disorder ◽

Cardiovascular Mortality ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Increased Risk

2210 – A phase II randomized, double-blind, placebo-controlled trial of GLYX-13 for the rapid treatment of major depressive disorder using central ratings

European Psychiatry ◽

10.1016/s0924-9338(13)77083-4 ◽

2013 ◽

Vol 28 ◽

pp. 1 ◽

Cited By ~ 1

Author(s):

D. Popp ◽

R. Burch ◽

J.B.W. Williams ◽

L.M. Price ◽

M.J. Detke

Keyword(s):

Depressive Disorder ◽

Phase Ii ◽

Controlled Trial ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo ◽

Rapid Treatment